{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:58:12Z","timestamp":1779879492573,"version":"3.53.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0092458","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T20:49:37Z","timestamp":1395780577000},"page":"e92458","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Changes in HbA1c Level over a 12-Week Follow-up in Patients with Type 2 Diabetes following a Medication Change"],"prefix":"10.1371","volume":"9","author":[{"given":"Jennifer A.","family":"Hirst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants","volume":"378","author":"G Danaei","year":"2011","journal-title":"Lancet"},{"key":"ref2","unstructured":"Kanavos P, van den Aardweg S, W S (2012) Diabetes expenditure, burden of disease and management in 5 EU countries. LSE Health, London School of Economics."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"IM Stratton","year":"2000","journal-title":"BMJ"},{"key":"ref4","unstructured":"NICE (2008) Type 2 diabetes: National clinical guideline for management in primary and secondary care (update). NICE clinical guideline 66: Royal College of Physicians."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc13-S011","article-title":"Standards of medical care in diabetes-2013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/jcp.2007.054304","article-title":"Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus","volume":"61","author":"ES Kilpatrick","year":"2008","journal-title":"J Clin Pathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1172\/JCI108436","article-title":"The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo","volume":"57","author":"HF Bunn","year":"1976","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0009-8981(83)90370-4","article-title":"Glucosylation of human haemoglobin a in red blood cells studied in vitro. Kinetics of the formation and dissociation of haemoglobin A1c","volume":"134","author":"HB Mortensen","year":"1983","journal-title":"Clin Chim Acta"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jdiacomp.2005.07.009","article-title":"Assessment of the relationship between glucose and A1c using kinetic modeling","volume":"20","author":"SM Osterman-Golkar","year":"2006","journal-title":"J Diabetes Complications"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1373\/clinchem.2010.161596","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"57","author":"DB Sacks","year":"2011","journal-title":"Clin Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2337\/diacare.16.9.1313","article-title":"The response of GHb to stepwise plasma glucose change over time in diabetic patients","volume":"16","author":"Y Tahara","year":"1993","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2337\/diacare.18.4.440","article-title":"Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level","volume":"18","author":"Y Tahara","year":"1995","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.29.01.06.dc05-1058","article-title":"Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial","volume":"29","author":"L Kennedy","year":"2006","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1515\/CCLM.2007.195","article-title":"Monitoring glycaemic control: is there evidence for appropriate use of routine measurement of glycated haemoglobin?","volume":"45","author":"GL Salvagno","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1463-1326.2009.01040.x","article-title":"Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus","volume":"11","author":"E Bosi","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.diabres.2011.07.034","article-title":"Glycated haemoglobin: what is the diagnostic yield at shortened testing intervals?","volume":"94","author":"TP Loh","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1373\/clinchem.2011.176487","article-title":"Inappropriate requesting of glycated hemoglobin (Hb A1c) is widespread: assessment of prevalence, impact of national guidance, and practice-to-practice variability","volume":"58","author":"OJ Driskell","year":"2012","journal-title":"Clin Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/193229680900300302","article-title":"Variation in the frequency of hemoglobin A1c (HbA1c) testing: population studies used to assess compliance with clinical practice guidelines and use of HbA1c to screen for diabetes","volume":"3","author":"AW Lyon","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2753.2006.00641.x","article-title":"The inappropriate use of HbA1c testing to monitor glycemia: is there evidence in laboratory data?","volume":"13","author":"P Akan","year":"2007","journal-title":"J Eval Clin Pract"},{"key":"ref20","unstructured":"NGSP (2014) List of NGSP Certified Methods."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1751-7176.2008.07572.x","article-title":"Predictive Validity of a Medication Adherence Measure in an Outpatient Setting","volume":"10","author":"DE Morisky","year":"2008","journal-title":"The Journal of Clinical Hypertension"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/jch.12037","article-title":"Association Between Antihypertensive Medication Adherence and Visit-to-Visit Variability of Blood Pressure","volume":"15","author":"P Muntner","year":"2013","journal-title":"The Journal of Clinical Hypertension"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jcjd.2013.01.017","article-title":"Monitoring Glycemic Control","volume":"37","author":"L Berard","year":"2013","journal-title":"Canadian Journal of Diabetes"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1021\/jm9605694","article-title":"Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone","volume":"39","author":"SP Tanis","year":"1996","journal-title":"J Med Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0092458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:24:33Z","timestamp":1588969473000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0092458"}},"subtitle":[],"editor":[{"given":"Noel Christopher","family":"Barengo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0092458","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]}}}